These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 33670477)

  • 1. Botulinum Toxin Type A to Improve Facial Symmetry in Facial Palsy: A Practical Guideline and Clinical Experience.
    de Sanctis Pecora C; Shitara D
    Toxins (Basel); 2021 Feb; 13(2):. PubMed ID: 33670477
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contralateral botulinum toxin injection to improve facial asymmetry after acute facial paralysis.
    Kim J
    Otol Neurotol; 2013 Feb; 34(2):319-24. PubMed ID: 23444480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Half-mirror biofeedback exercise in combination with three botulinum toxin A injections for long-lasting treatment of facial sequelae after facial paralysis.
    Lee JM; Choi KH; Lim BW; Kim MW; Kim J
    J Plast Reconstr Aesthet Surg; 2015 Jan; 68(1):71-8. PubMed ID: 25444667
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Botulinum toxin to improve lower facial symmetry in facial nerve palsy.
    Sadiq SA; Khwaja S; Saeed SR
    Eye (Lond); 2012 Nov; 26(11):1431-6. PubMed ID: 22975654
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contralateral botulinum injections improve drinking ability and facial symmetry in patients with facial paralysis.
    Krohel GB; Cipollo CL; Gaddipati K
    Am J Ophthalmol; 2005 Mar; 139(3):540. PubMed ID: 15767069
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term sequelae treatment of peripheral facial paralysis with botulinum toxin type A: Repartition and kinetics of doses used.
    Risoud M; Aljudaibi N; Duquennoy-Martinot V; Guerreschi P
    Ann Chir Plast Esthet; 2016 Feb; 61(1):10-5. PubMed ID: 25953657
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mirror biofeedback rehabilitation after administration of single-dose botulinum toxin for treatment of facial synkinesis.
    Azuma T; Nakamura K; Takahashi M; Ohyama S; Toda N; Iwasaki H; Kalubi B; Takeda N
    Otolaryngol Head Neck Surg; 2012 Jan; 146(1):40-5. PubMed ID: 21965443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. UNILATERAL FRONTALIS MUSCLE PARALYSIS: MANAGEMENT WITH BOTULINUM TOXIN A (CASE REPORTS).
    Goldman A; Wollina U
    Georgian Med News; 2018 Feb; (Issue):73-77. PubMed ID: 29578428
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treating Buccinator With Botulinum Toxin in Patients With Facial Synkinesis: A Previously Overlooked Target.
    Wei LA; Diels J; Lucarelli MJ
    Ophthalmic Plast Reconstr Surg; 2016; 32(2):138-41. PubMed ID: 26325382
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Facial asymmetry in patients with hemifacial spasm before and after botulinum toxin A treatment.
    Xiao L; Pan Y; Zhang X; Hu Y; Cai L; Nie Z; Pan L; Li B; He Y; Jin L
    Neurol Sci; 2016 Nov; 37(11):1807-1813. PubMed ID: 27431279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuromodulator for the Treatment of Congenital Unilateral Lower Lip Palsy.
    Krane NA; Markey JD; Loyo M
    Ann Otol Rhinol Laryngol; 2019 Jan; 128(1):62-65. PubMed ID: 30347990
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Buccinator Treatment With Botulinum Toxin in Facial Synkinesis.
    Patel PN; Owen SR; Norton CP; Emerson BT; Bronaugh AB; Ries WR; Stephan SJ
    JAMA Facial Plast Surg; 2018 May; 20(3):196-201. PubMed ID: 28973100
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The WE-Study: does botulinum toxin A make walking easier in children with cerebral palsy?: Study protocol for a randomized controlled trial.
    Brændvik SM; Roeleveld K; Andersen GL; Raftemo AE; Ramstad K; Majkic-Tajsic J; Lamvik T; Lund B; Follestad T; Vik T
    Trials; 2017 Feb; 18(1):58. PubMed ID: 28166806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Five-Year Prospective Study of Quality of Life in Hemifacial Spasm Treated with Abo-Botulinum Toxin A.
    Kongsaengdao S; Maneeton N; Maneeton B
    Toxins (Basel); 2021 Mar; 13(3):. PubMed ID: 33809486
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Practical Use of AbobotulinumtoxinA in Aesthetics.
    Kane MA; Monheit G
    Aesthet Surg J; 2017 May; 37(suppl_1):S12-S19. PubMed ID: 28388719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Platysma synkinesis in facial palsy and botulinum toxin type A.
    Dall'Angelo A; Mandrini S; Sala V; Pavese C; Carlisi E; Comelli M; Toffola ED
    Laryngoscope; 2014 Nov; 124(11):2513-7. PubMed ID: 24764160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Therapeutic strategies in post-facial paralysis synkinesis in pediatric patients.
    Terzis JK; Karypidis D
    J Plast Reconstr Aesthet Surg; 2012 Aug; 65(8):1009-18. PubMed ID: 22483723
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of peripheral facial palsy treatment with Botulinum Toxin type A.
    Hernández Herrero D; Abdel Muti García E; López Araujo J; Alfonso Barrera E; Moraleda Pérez S
    J Plast Reconstr Aesthet Surg; 2022 Jan; 75(1):271-277. PubMed ID: 34266804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Weakening of Ipsilateral Depressor Anguli Oris on Smile Symmetry in Postparalysis Facial Palsy.
    Jowett N; Malka R; Hadlock TA
    JAMA Facial Plast Surg; 2017 Jan; 19(1):29-33. PubMed ID: 27658020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cutaneous cooling to manage botulinum toxin injection-associated pain in patients with facial palsy: A randomised controlled trial.
    Pucks N; Thomas A; Hallam MJ; Venables V; Neville C; Nduka C
    J Plast Reconstr Aesthet Surg; 2015 Dec; 68(12):1701-5. PubMed ID: 26385134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.